Respiratory microbiota: addressing clinical questions, informing clinical practice

GB Rogers, D Shaw, RL Marsh, MP Carroll, DJ Serisier… - Thorax, 2015 - thorax.bmj.com
Over the last decade, technological advances have revolutionised efforts to understand the
role played by microbes in airways disease. With the application of ever more sophisticated …

Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients

A Hérivaux, JR Willis, T Mercier, K Lagrou… - Thorax, 2022 - thorax.bmj.com
Rationale Recent studies have revealed that the lung microbiota of critically ill patients is
altered and predicts clinical outcomes. The incidence of invasive fungal infections, namely …

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations

D Mayhew, N Devos, C Lambert, JR Brown, SC Clarke… - Thorax, 2018 - thorax.bmj.com
Background Alterations in the composition of the lung microbiome associated with adverse
clinical outcomes, known as dysbiosis, have been implicated with disease severity and …

Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis

RJ Boyton, CJ Reynolds, KJ Quigley… - Clinical & …, 2013 - academic.oup.com
Recent studies analysing immunogenetics and immune mechanisms controlling
susceptibility to chronic bacterial infection in bronchiectasis implicate dysregulated immunity …

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis

LA Carmody, LJ Caverly, BK Foster, MAM Rogers… - PLoS …, 2018 - journals.plos.org
Bacteria that infect the airways of persons with cystic fibrosis (CF) include a group of well-
described opportunistic pathogens as well as numerous, mainly obligate or facultative …

Analysis of lung microbiota in bronchoalveolar lavage, protected brush and sputum samples from subjects with mild-to-moderate cystic fibrosis lung disease

DA Hogan, SD Willger, EL Dolben, TH Hampton… - PloS one, 2016 - journals.plos.org
Individuals with cystic fibrosis (CF) often acquire chronic lung infections that lead to
irreversible damage. We sought to examine regional variation in the microbial communities …

The respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis

R Invernizzi, BG Wu, J Barnett, P Ghai… - American journal of …, 2021 - atsjournals.org
Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after
repeated exposure and sensitization to inhaled antigens. The lung microbiome is …

[HTML][HTML] Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis

TWV Daniels, GB Rogers, FA Stressmann… - Journal of Cystic …, 2013 - Elsevier
BACKGROUND: A diverse array of bacterial species is present in the CF airways, in addition
to those recognised as clinically important. Here, we investigated the relative impact of …

Lung microbiota across age and disease stage in cystic fibrosis

B Coburn, PW Wang, J Diaz Caballero, ST Clark… - Scientific reports, 2015 - nature.com
Understanding the significance of bacterial species that colonize and persist in cystic fibrosis
(CF) airways requires a detailed examination of bacterial community structure across a …

Microbial epidemiology of the cystic fibrosis airways: past, present, and future

CS Thornton, MD Parkins - Seminars in Respiratory and …, 2023 - thieme-connect.com
Progressive obstructive lung disease secondary to chronic airway infection, coupled with
impaired host immunity, is the leading cause of morbidity and mortality in cystic fibrosis (CF) …